loader
Please Wait
Applying Filters...

Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X

List of Certificates of Suitability (CEPs) for cep_2021_391___rev_02 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Zhejiang Hisun Pharmaceutical Co., Ltd. Taizhou City CN (1)

filter

01 Milbemycin oxime for veterinary use (1)

filter

01 China (1)

filter

01 Valid (1)

URL Supplier Web Content
CEP 2021-391 - Rev 02
Valid
Chemical
2024-04-30
2536
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for Certificates of Suitability (CEPs) for CEP 2021-391 - Rev 02 of Zhejiang Hisun Pharmaceutical Co., Ltd. Taizhou City Cn

Looking for Certificates of Suitability (CEPs) for CEP 2021-391 - Rev 02 of Zhejiang Hisun Pharmaceutical Co., Ltd. Taizhou City Cn 1

20

Zhejiang Hisun Pharmaceutical Co., Ltd. Taizhou City Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their significant offerings is Milbemycin oxime for veterinary use, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2021-391 - Rev 02

This Chemical Type CEP, issued on April 30, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 2536 associated with this CEP further emphasizes

Post Enquiry
POST ENQUIRY